Patents by Inventor Kathleen M. Lee

Kathleen M. Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LIQUID PHARMACEUTICAL FORMULATIONS OF PALONOSETRON
    Publication number: 20180193262
    Abstract: The present invention relates to shelf-stable liquid formulations of palonosetron for reducing chemotherapy and radiotherapy induced emesis with palonosetron. The formulations are particularly useful in the preparation of intravenous and oral liquid medicaments.
    Type: Application
    Filed: September 19, 2017
    Publication date: July 12, 2018
    Inventors: Giorgio Calderari, Daniele Bonadeo, Roberta Cannella, Alberto Macciocchi, Andrew Miksztal, Thomas Malefyt, Kathleen M. Lee, Carmine Panuccio
  • Antidiabetic Solid Pharmaceutical Compositions
    Publication number: 20170273969
    Abstract: Provided are pharmaceutical compositions in solid form comprising a selective modulator of PPAR-? suitable for oral dosage to treat subjects having PPAR-? mediated conditions. Provided further are methods of manufacturing the compositions, and methods of treating a PPAR-? mediated condition.
    Type: Application
    Filed: June 12, 2017
    Publication date: September 28, 2017
    Inventors: Kathleen M. Lee, Linda Higgins, Dennis Lanfear
  • Solid pharmaceutical compositions of ppary modulator
    Patent number: 9675603
    Abstract: Provided are pharmaceutical compositions in solid form comprising a selective modulator of PPAR-? suitable for oral dosage to treat subjects having PPAR-? mediated conditions. Provided further are methods of manufacturing the compositions, and methods of treating a PPAR-? mediated condition.
    Type: Grant
    Filed: September 19, 2011
    Date of Patent: June 13, 2017
    Assignee: InteKrin Therapeutics, Inc.
    Inventors: Kathleen M. Lee, Linda Higgins, Dennis Lanfear
  • LIQUID PHARMACEUTICAL FORMULATIONS OF PALONOSETRON
    Publication number: 20170042807
    Abstract: The present invention relates to shelf-stable liquid formulations of palonosetron for reducing chemotherapy and radiotherapy induced emesis with palonosetron. The formulations are particularly useful in the preparation of intravenous and oral liquid medicaments.
    Type: Application
    Filed: August 18, 2016
    Publication date: February 16, 2017
    Inventors: Giorgio Calderari, Daniele Bonadeo, Roberta Cannella, Alberto Macciocchi, Andrew Miksztal, Thomas Malefyt, Kathleen M. Lee
  • LIQUID PHARMACEUTICAL FORMULATIONS OF PALONOSETRON
    Publication number: 20160317440
    Abstract: The present invention relates to shelf-stable liquid formulations of palonosetron for reducing chemotherapy and radiotherapy induced emesis with palonosetron. The formulations are particularly useful in the preparation of intravenous and oral liquid medicaments.
    Type: Application
    Filed: July 14, 2016
    Publication date: November 3, 2016
    Applicant: Helsinn Healthcare SA
    Inventors: Giorgio Calderari, Daniele Bonadeo, Roberta Cannella, Andrew Miksztal, Thomas Malefyt, Kathleen M. Lee
  • LIQUID PHARMACEUTICAL FORMULATIONS OF PALONOSETRON
    Publication number: 20160296510
    Abstract: The present invention relates to shelf-stable liquid formulations of palonosetron for reducing chemotherapy and radiotherapy induced emesis with palonosetron. The formulations are particularly useful in the preparation of intravenous and oral liquid medicaments.
    Type: Application
    Filed: June 22, 2016
    Publication date: October 13, 2016
    Applicant: Helsinn Healthcare SA
    Inventors: Giorgio Calderari, Daniele Bonadeo, Roberta Cannella, Alberto Macciocchi, Andrew Miksztal, Thomas Malefyt, Kathleen M Lee
  • Liquid pharmaceutical formulations of palonosetron
    Patent number: 9457021
    Abstract: The present invention relates to shelf-stable liquid formulations of palonosetron for reducing chemotherapy and radiotherapy induced emesis with palonosetron. The formulations are particularly useful in the preparation of intravenous and oral liquid medicaments.
    Type: Grant
    Filed: June 22, 2016
    Date of Patent: October 4, 2016
    Assignee: Helsinn Healthcare SA
    Inventors: Giorgio Calderari, Daniele Bonadeo, Roberta Cannella, Alberto Macciocchi, Andrew Miksztal, Thomas Malefyt, Kathleen M Lee
  • Liquid pharmaceutical formulations of palonosetron
    Patent number: 9457020
    Abstract: The present invention relates to shelf-stable liquid formulations of palonosetron for reducing chemotherapy and radiotherapy induced emesis with palonosetron. The formulations are particularly useful in the preparation of intravenous and oral liquid medicaments.
    Type: Grant
    Filed: September 16, 2015
    Date of Patent: October 4, 2016
    Assignee: Helsinn Healthcare SA
    Inventors: Giorgio Calderari, Daniele Bonadeo, Roberta Cannella, Andrew Miksztal, Thomas Malefyt, Kathleen M Lee
  • Liquid pharmaceutical formulations of palonosetron
    Patent number: 9439854
    Abstract: The present invention relates to shelf-stable liquid formulations of palonosetron for reducing chemotherapy and radiotherapy induced emesis with palonosetron. The formulations are particularly useful in the preparation of intravenous and oral liquid medicaments.
    Type: Grant
    Filed: July 7, 2015
    Date of Patent: September 13, 2016
    Assignee: Helsinn Healthcare SA
    Inventors: Giorgio Calderari, Daniele Bonadeo, Roberta Cannella, Alberto Macciocchi, Andrew Miksztal, Thomas Malefyt, Kathleen M Lee
  • Liquid pharmaceutical formulations of palonosetron
    Patent number: 9308266
    Abstract: The present invention relates to shelf-stable liquid formulations of palonosetron for reducing chemotherapy and radiotherapy induced emesis with palonosetron. The formulations are particularly useful in the preparation of intravenous and oral liquid medicaments.
    Type: Grant
    Filed: November 4, 2013
    Date of Patent: April 12, 2016
    Assignees: HELSINN HEALTHCARE SA, ROCHE PALO ALTO LLC
    Inventors: Giorgio Calderari, Daniele Bonadeo, Roberta Cannella, Alberto Macciocchi, Andrew Miksztal, Thomas Malefyt, Kathleen M Lee, Carmine Panuccio
  • LIQUID PHARMACEUTICAL FORMULATIONS OF PALONOSETRON
    Publication number: 20160000773
    Abstract: The present invention relates to shelf-stable liquid formulations of palonosetron for reducing chemotherapy and radiotherapy induced emesis with palonosetron. The formulations are particularly useful in the preparation of intravenous and oral liquid medicaments.
    Type: Application
    Filed: September 16, 2015
    Publication date: January 7, 2016
    Applicants: Roche Palo Alto LLC
    Inventors: Giorgio Calderari, Daniele Bonadeo, Roberta Cannella, Andrew Miksztal, Thomas Malefyt, Kathleen M. Lee
  • Liquid pharmaceutical formulations of palonosetron
    Patent number: 9173942
    Abstract: The present invention relates to shelf-stable liquid formulations of palonosetron for reducing chemotherapy and radiotherapy induced emesis with palonosetron. The formulations are particularly useful in the preparation of intravenous and oral liquid medicaments.
    Type: Grant
    Filed: May 24, 2013
    Date of Patent: November 3, 2015
    Assignees: HELSINN HEALTHCARE SA, Roche Palo Alto LLC
    Inventors: Giorgio Calderari, Daniele Bonadeo, Roberta Cannella, Alberto Macciocchi, Andrew Miksztal, Thomas Malefyt, Kathleen M Lee
  • LIQUID PHARMACEUTICAL FORMULATIONS OF PALONOSETRON
    Publication number: 20150306032
    Abstract: The present invention relates to shelf-stable liquid formulations of palonosetron for reducing chemotherapy and radiotherapy induced emesis with palonosetron. The formulations are particularly useful in the preparation of intravenous and oral liquid medicaments.
    Type: Application
    Filed: July 7, 2015
    Publication date: October 29, 2015
    Applicants: Helsinn Healthcare SA, Roche Palo Alto LLC
    Inventors: Giorgio Calderari, Daniele Bonadeo, Roberta Cannella, Andrew Miksztal, Thomas Malefyt, Kathleen M Lee
  • Liquid pharmaceutical formulations of palonosetron
    Patent number: 9125905
    Abstract: The present invention relates to shelf-stable liquid formulations of palonosetron for reducing chemotherapy and radiotherapy induced emesis with palonosetron. The formulations are particularly useful in the preparation of intravenous and oral liquid medicaments.
    Type: Grant
    Filed: January 15, 2015
    Date of Patent: September 8, 2015
    Assignees: Helsinn Healthcare SA, Roche Palo Alto LLC
    Inventors: Giorgio Calderari, Daniele Bonadeo, Roberta Cannella, Alberto Macciocchi, Andrew Miksztal, Thomas Malefyt, Kathleen M Lee
  • Liquid pharmaceutical formulations of palonosetron
    Patent number: 9066980
    Abstract: The present invention relates to shelf-stable liquid formulations of palonosetron for reducing chemotherapy and radiotherapy induced emesis with palonosetron. The formulations are particularly useful in the preparation of intravenous and oral liquid medicaments.
    Type: Grant
    Filed: May 24, 2013
    Date of Patent: June 30, 2015
    Assignees: Helsinn Healthcare SA, Roche Palo Alto LLC
    Inventors: Giorgio Calderari, Daniele Bonadeo, Roberta Cannella, Alberto Macciocchi, Andrew Miksztal, Thomas Malefyt, Kathleen M Lee
  • LIQUID PHARMACEUTICAL FORMULATIONS OF PALONOSETRON
    Publication number: 20150141454
    Abstract: The present invention relates to shelf-stable liquid formulations of palonosetron for reducing chemotherapy and radiotherapy induced emesis with palonosetron. The formulations are particularly useful in the preparation of intravenous and oral liquid medicaments.
    Type: Application
    Filed: January 15, 2015
    Publication date: May 21, 2015
    Inventors: Giorgio Calderari, Daniele Bonadeo, Roberta Cannella, Alberto Macciocchi, Andrew Miksztal, Thomas Malefyt, Kathleen M Lee
  • Liquid pharmaceutical formulations of palonosetron
    Patent number: 8729094
    Abstract: The present invention relates to shelf-stable liquid formulations of palonosetron for reducing chemotherapy and radiotherapy induced emesis with palonosetron. The formulations are particularly useful in the preparation of intravenous and oral liquid medicaments.
    Type: Grant
    Filed: May 24, 2013
    Date of Patent: May 20, 2014
    Assignees: Helsinn Healthcare SA, Roche Palo Alto LLC
    Inventors: Giorgio Calderari, Daniele Bonadeo, Roberta Cannella, Alberto Macciocchi, Andrew Miksztal, Thomas Malefyt, Kathleen M Lee
  • LIQUID PHARMACEUTICAL FORMULATIONS OF PALONOSETRON
    Publication number: 20140097114
    Abstract: The present invention relates to shelf-stable liquid formulations of palonosetron for reducing chemotherapy and radiotherapy induced emesis with palonosetron. The formulations are particularly useful in the preparation of intravenous and oral liquid medicaments.
    Type: Application
    Filed: November 4, 2013
    Publication date: April 10, 2014
    Applicants: Roche Palo Alto LLC, Helsinn Healthcare S.A.
    Inventors: Giorgio Calderari, Daniele Bonadeo, Roberta Cannella, Alberto Macciocchi, Andrew Miksztal, Thomas Malefyt, Kathleen M Lee, Carmine Panuccio
  • LIQUID PHARMACEUTICAL FORMULATIONS OF PALONOSETRON
    Publication number: 20140039000
    Abstract: The present invention relates to shelf-stable liquid formulations of palonosetron for reducing chemotherapy and radiotherapy induced emesis with palonosetron. The formulations are particularly useful in the preparation of intravenous and oral liquid medicaments.
    Type: Application
    Filed: October 14, 2013
    Publication date: February 6, 2014
    Applicants: Roche Palo Alto LLC, Helsinn Healthcare S.A.
    Inventors: Giorgio Calderari, Daniele Bonadeo, Roberta Cannella, Alberto Macciocchi, Andrew Miksztal, Thomas Malefyt, Kathleen M. Lee
  • Liquid pharmaceutical formulations of palonosetron
    Patent number: 8598219
    Abstract: The present invention relates to shelf-stable liquid formulations of palonosetron for reducing chemotherapy and radiotherapy induced emesis with palonosetron. The formulations are particularly useful in the preparation of intravenous and oral liquid medicaments.
    Type: Grant
    Filed: May 23, 2013
    Date of Patent: December 3, 2013
    Assignees: Helsinn Healthcare SA, Roche Palo Alto LLC
    Inventors: Giorgio Calderari, Daniele Bonadeo, Roberta Cannella, Alberto Macciocchi, Andrew Miksztal, Thomas Malefyt, Kathleen M Lee, Carmine Panuccio